Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.

Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.

Dades bibliogràfiques
Autor principal:	Wilcock, G
Format:	Journal article
Idioma:	English
Publicat:	1994

Ítems similars

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
per: Wilcock, G
Publicat: (1990)

Negative conclusions not justified [4]
per: Wilcock, G, et al.
Publicat: (1994)

Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
per: Forsyth, DR, et al.
Publicat: (1989)

Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers?
per: Wilcock, G
Publicat: (1994)

Tacrine for Alzheimer's disease.
per: Qizilbash, N, et al.
Publicat: (2000)

Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.
per: Roberts, C, et al.
Publicat: (1998)

Tacrine for senile dementia of Alzheimer's or Lewy body type.
per: Wilcock, G, et al.
Publicat: (1994)

Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease.
per: Ford, J, et al.
Publicat: (1993)

Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study.
per: Forsyth, DR, et al.
Publicat: (1989)

Long-term use of tacrine
per: Wilcock, G, et al.
Publicat: (1994)

Long-term use of tacrine.
per: Wilcock, G, et al.
Publicat: (1994)

Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
per: Qizilbash, N, et al.
Publicat: (1998)

PHARMACOKINETICS OF TACRINE HYDROCHLORIDE IN PATIENTS WITH DEMENTIA
per: Forsyth, D, et al.
Publicat: (1989)

The presence of leuko-araiosis in patients with Alzheimer's disease predicts poor tolerance to tacrine, but does not discriminate responders from non-responders.
per: Amar, K, et al.
Publicat: (1997)

In-silico investigations of novel tacrine derivatives potency against Alzheimer's disease
per: Mohamed El fadili, et al.
Publicat: (2024-03-01)

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
per: Youssef Dgachi, et al.
Publicat: (2019-01-01)

Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease
per: Wen-Yu Wu, et al.
Publicat: (2017-01-01)

An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.
per: Wilcock, G, et al.
Publicat: (1993)

ADVANCES IN THE MANAGEMENT OF ALZHEIMERS-DISEASE - THE ROLE OF TACRINE - A SATELLITE SYMPOSIUM HELD DURING THE 6TH CONGRESS OF THE INTERNATIONAL-PSYCHOGERIATRIC-ASSOCIATION SEPTEMBER 8, 1993, BERLIN, GERMANY - INTRODUCTION AND OVERVIEW
per: Forette, F, et al.
Publicat: (1994)

Can blood concentrations of tacrine hydrochloride (THA) predict the risk of adverse effects?
per: Ford, J, et al.
Publicat: (1993)

A double-blind, placebo-controlled study of tacrine in patients with Alzheimer's disease using SPET.
per: Prentice, N, et al.
Publicat: (1996)

Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
per: Yao Chen, et al.
Publicat: (2018-01-01)

New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer’s Disease
per: Rajeshwari Rajeshwari, et al.
Publicat: (2019-02-01)

Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer’s Disease
per: Gaia Fancellu, et al.
Publicat: (2020-01-01)

Field triage in trauma – do the data really justify the conclusions?
per: Sandberg Mårten
Publicat: (2009-05-01)

Structural, harmonic force field and vibrational studies of cholinesterase inhibitor tacrine used for treatment of Alzheimer's disease
per: Tom Sundius, et al.
Publicat: (2023-06-01)

QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy
per: Eva Ramos, et al.
Publicat: (2019-04-01)

RE: Field triage in trauma – do the data really justify the conclusions?
per: Krüger Andreas, et al.
Publicat: (2009-05-01)

Design, synthesis and evaluation of OA-tacrine hybrids as cholinesterase inhibitors with low neurotoxicity and hepatotoxicity against Alzheimer’s disease
per: Huali Yang, et al.
Publicat: (2023-12-01)

Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
per: Jie Zhu, et al.
Publicat: (2018-01-01)

Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer’s Disease
per: Yingbo Fu, et al.
Publicat: (2016-10-01)

New Multifunctional Agents for Potential Alzheimer’s Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones
per: Natalia A. Elkina, et al.
Publicat: (2022-10-01)

Modified Tacrine Derivatives as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Synthesis, Biological Evaluation, and Molecular Modeling Study
per: Salma Fares, et al.
Publicat: (2023-07-01)

Tacrine-induced tachyphylaxis in gastric smooth muscles
per: Prissadova Natalia, et al.
Publicat: (2012-12-01)

Determination of tacrine hydrochloride in human serum by chloroform extraction, reversed-phase high-performance liquid chromatography and fluorimetric detection.
per: Forsyth, DR, et al.
Publicat: (1988)

Formulation, Characterization and Evaluation against SH-SY5Y Cells of New Tacrine and Tacrine-MAP Loaded with Lipid Nanoparticles
per: Sara Silva, et al.
Publicat: (2020-10-01)

Design, Synthesis and Molecular Modeling Study of Radiotracers Based on Tacrine and Its Derivatives for Study on Alzheimer’s Disease and Its Early Diagnosis
per: Przemysław Koźmiński, et al.
Publicat: (2024-03-01)

Design, synthesis and biological evaluation of novel N-phosphorylated and O-phosphorylated tacrine derivatives as potential drugs against Alzheimer’s disease
per: Maja Przybyłowska, et al.
Publicat: (2022-12-01)

In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease
per: Huang ST, et al.
Publicat: (2024-01-01)

Determination of anticancer and antibacterial activities of disubstituted tacrine derivatives
per: Salih Ökten, et al.
Publicat: (2019-10-01)